Literature DB >> 8769529

The spectrum of adult adenovirus pneumonia.

P Retalis1, C Strange, R Harley.   

Abstract

Adenovirus pneumonia is endemic among infants and children. We report an adult case of adenovirus pneumonia causing respiratory failure and infection in the patient's spouse. The case in the spouse presented as an exacerbation of COPD.

Entities:  

Mesh：

Year:  1996        PMID： 8769529     DOI： 10.1378/chest.109.6.1656

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  5 in total

1.  Development of a bead-based suspension array for the detection of pathogens in acute respiratory tract infections.

Authors:  Yu-Sheng Chen; Hong-Ru Li; Wei Zhang; Zhi-Dan Hua; Xiao-Hong Lin; Meng-Qing Lin; Wen-Sen Huang; Li-Ping Huang; Xiao-Li Yu; Neng-Luan Xu; Ming Lin; Bao-Song Xie; Xiao-Na Shen; Jian-Feng Xie; Yi Wang; Meng Huang; Yan-An Wu; Xin-Lan Hu
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-13

2.  Severe community-acquired adenovirus pneumonia in an immunocompetent 44-year-old woman: a case report and review of the literature.

Authors:  Tristan W Clark; Daniel H Fleet; Martin J Wiselka
Journal:  J Med Case Rep       Date:  2011-06-30

3.  Clinical Features and Radiological Findings of Adenovirus Pneumonia Associated with Progression to Acute Respiratory Distress Syndrome: A Single Center Study in 19 Adult Patients.

Authors:  Min Jae Cha; Myung Jin Chung; Kyung Soo Lee; Tae Jung Kim; Tae Sung Kim; Semin Chong; Jungho Han
Journal:  Korean J Radiol       Date:  2016-10-31       Impact factor: 3.500

4.  Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing.

Authors:  Li Gu; Zhenjia Liu; Xiaoli Li; Jiuxin Qu; Wenda Guan; Yingmei Liu; Shufan Song; Xiaomin Yu; Bin Cao
Journal:  J Clin Virol       Date:  2012-05-18       Impact factor: 3.168

Review 5.  Medical treatment of viral pneumonia including SARS in immunocompetent adult.

Authors:  V C C Cheng; B S F Tang; A K L Wu; C M Chu; K Y Yuen
Journal:  J Infect       Date:  2004-11       Impact factor: 6.072
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.